Avalo TherapeuticsAVTX
那斯達克 · USD
12.36
+0.77
(+6.64%)
收盤 10/21 03:59 (UTC+8)
10/21 03:59 (UTC+8)
Avalo TherapeuticsAVTX
12.36
+0.77
(+6.64%)
財務數據
損益表
- -
- -
- 0.00
- 0.00
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -22.89
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | 59 | - | - | - | 192 | 249 | - | - |
營業成本 | - | - | - | - | - | - | 87 | -716 | 343 | -80 |
營業毛利 | - | - | 59 | - | - | - | 105 | 965 | -343 | 80 |
營業費用 | 31,518 | 20,901 | 19,801 | 19,199 | 19,315 | 14,669 | 13,416 | - | - | - |
研發費用 | 23,419 | 14,047 | 13,267 | 13,622 | 14,072 | 9,123 | 8,183 | 9,538 | 4,600 | 2,116 |
推銷及管理費用 | 8,099 | 6,854 | 6,534 | 5,577 | 5,243 | 5,546 | 5,233 | 4,287 | 4,528 | 3,193 |
非經常性項目費用 | - | - | - | - | - | - | - | - | 103 | 27,538 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -31,518 | -20,901 | -19,742 | -19,199 | -19,315 | -14,669 | -13,311 | -12,860 | -9,574 | -32,767 |
其他收入及費用 | -4,823 | 1,283 | 6,152 | -11,415 | -1,434 | 1,528 | -25,231 | 34,920 | 106,906 | -88,516 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -36,341 | -19,618 | -13,590 | -30,614 | -20,749 | -13,141 | -35,225 | 23,023 | 98,470 | -121,283 |
所得稅 | 17 | 12 | 130 | 11 | 16 | 8 | 114 | -14 | 7 | 7 |
稅後純益 | -36,358 | -19,630 | -13,720 | -30,625 | -20,765 | -13,149 | -35,339 | 23,037 | 98,463 | -121,290 |
基本每股稅後盈餘(元) | -0.83 | -0.98 | -0.48 | -2.19 | -1.92 | -1.25 | -878.18 | 0.98 | 4.21 | -141.14 |
稀釋每股稅後盈餘(元) | -0.77 | -0.98 | -0.37 | -2.29 | -1.93 | -1.25 | 1.72 | 8.00 | 110.51 | -141.14 |
基本平均股數(千股) | 43602.00 | 20106.00 | 18276.00 | 14000.00 | 10829.00 | 10514.00 | 11295.00 | 5546.00 | 1034.00 | 859.00 |
稀釋平均股數(千股) | 43602.00 | 20106.00 | 18276.00 | 14000.00 | 10829.00 | 10514.00 | 18311.00 | 10784.00 | 7653.00 | 859.00 |
還原基本每股稅後盈餘(元) | -0.83 | -0.98 | -0.48 | -2.19 | -1.92 | -1.25 | -878.18 | 0.98 | 4.21 | -141.14 |
還原稀釋每股稅後盈餘(元) | -0.77 | -0.98 | -0.37 | -2.29 | -1.93 | -1.25 | 1.72 | 8.00 | 110.51 | -141.14 |
還原基本平均股數(千股) | 43,602 | 20,106 | 18,276 | 14,000 | 10,829 | 10,514 | 11,295 | 5,546 | 1,034 | 859 |
還原稀釋平均股數(千股) | 43,602 | 20,106 | 18,276 | 14,000 | 10,829 | 10,514 | 18,311 | 10,784 | 7,653 | 859 |
EBITDA(千元) | -36,742 | -19,707 | -13,771 | -30,902 | -20,761 | -13,006 | -35,157 | 23,057 | 98,503 | -121,249 |